Susan M. Chang

39.2k total citations · 8 hit papers
292 papers, 22.6k citations indexed

About

Susan M. Chang is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susan M. Chang has authored 292 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Genetics, 78 papers in Pulmonary and Respiratory Medicine and 68 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susan M. Chang's work include Glioma Diagnosis and Treatment (235 papers), Brain Metastases and Treatment (70 papers) and Meningioma and schwannoma management (42 papers). Susan M. Chang is often cited by papers focused on Glioma Diagnosis and Treatment (235 papers), Brain Metastases and Treatment (70 papers) and Meningioma and schwannoma management (42 papers). Susan M. Chang collaborates with scholars based in United States, Jamaica and Netherlands. Susan M. Chang's co-authors include Michael D. Prados, Kathleen R. Lamborn, Mitchel S. Berger, Susan Walker, Patrick Y. Wen, Sally Grantham‐McGregor, Martin J. van den Bent, Michael W. McDermott, Michael A. Vogelbaum and Timothy F. Cloughesy and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Susan M. Chang

284 papers receiving 22.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

2010 2.7k citations Patrick Y. Wen, David R. Macdonald et al. Journal of Clinical Oncology profile →
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

2008 904 citations Kathleen R. Lamborn, Susan M. Chang et al. Journal of Clinical Oncology profile →
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

1999 608 citations Michael D. Prados, Susan M. Chang et al. Journal of Clinical Oncology profile →
Labor market returns to an early childhood stimulation intervention in Jamaica

2014 457 citations Susan Walker, Susan M. Chang et al. profile →
Current and future strategies for treatment of glioma

2016 426 citations Susan M. Chang et al. profile →
Response Assessment in Neuro-Oncology Clinical Trials

2017 279 citations Patrick Y. Wen, Susan M. Chang et al. Journal of Clinical Oncology profile →
Glioma

2024 173 citations Michael Weller, Patrick Y. Wen et al. Nature Reviews Disease Primers profile →
Primary brain tumours in adults

2023 157 citations Martin J. van den Bent, Susan M. Chang et al. profile →

Peers

Countries citing papers authored by Susan M. Chang

Since Specialization

Citations

This map shows the geographic impact of Susan M. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Chang more than expected).

Fields of papers citing papers by Susan M. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Chang. The network helps show where Susan M. Chang may publish in the future.

Co-authorship network of co-authors of Susan M. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Chang. A scholar is included among the top collaborators of Susan M. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Chang. Susan M. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glioma breakdown → 2024 ·Nature Reviews Disease Primers ·Michael Weller, Patrick Y. Wen, Susan M. Chang, Linda Dirven, Michael Lim, Michelle Monje, Guido Reifenberger	173
2	Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward 2024 ·Neuro-Oncology Advances ·Emily J. Smith, Anant Naik, (unknown), Patrick Y. Wen, Michael Lim, Susan M. Chang, Isabelle M. Germano	2
3	Enhancing neuro-oncology care through equity-driven applications of artificial intelligence 2024 ·Neuro-Oncology ·(unknown), Youssef Sibih, (unknown), Susan M. Chang, Patrick Y. Wen, Annette M. Molinaro, Ugonma Chukwueke, (unknown), Sadhana Jackson, J Ricardo McFaline-Figueroa, Alyx B. Porter, Shawn L. Hervey‐Jumper	5
4	Maternal feeding styles in infancy predict child body mass index z-scores at 72 months: findings from a cohort of Jamaican children 2023 ·Frontiers in Public Health ·(unknown), (unknown), Marshall K. Tulloch‐Reid, Susan M. Chang, Susan Walker	0
5	RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future 2023 ·Neuro-Oncology ·Patrick Y. Wen, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang	12
6	Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort 2023 ·Neuro-Oncology ·(unknown), Ugonma Chukwueke, Sadhana Jackson, Eudocia Q. Lee, J Ricardo McFaline-Figueroa, Nicole E. Willmarth, (unknown), Ichiro Kawachi, David Arons, Susan M. Chang, Evanthia Galanis, Shawn L. Hervey‐Jumper, Patrick Y. Wen, Alyx B. Porter	9
7	Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults 2023 ·Neuro-Oncology ·Michael Weller, Émilie Le Rhun, Martin J. van den Bent, Susan M. Chang, Timothy F. Cloughesy, Roland Goldbrunner, Yong-Kil Hong, Rakesh Jalali, Michael D. Jenkinson, Giuseppe Minniti, Motoo Nagane, Evangelia Razis, Patrick Roth, Roberta Rudà, Ghazaleh Tabatabai, Patrick Y. Wen, Susan Short, Matthias Preusser	23
8	Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer 2022 ·Nature Communications ·Carter J. Barger, Abigail K. Suwala, Katarzyna M. Soczek, Albert Wang, (unknown), Chibo Hong, Jennifer A. Doudna, Susan M. Chang, Joanna J. Phillips, David A. Solomon, J Costello	13
9	Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement 2021 ·Clinical Cancer Research ·Stephen Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw	104
10	Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members 2021 ·Neuro-Oncology Practice ·Shannon P. Fortin Ensign, (unknown), Susan M. Chang, Maciej M. Mrugała	2
11	Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review 2020 ·Neuro-Oncology ·Michael A. Vogelbaum, Daria Krivosheya, Hamid Borghei‐Razavi, Nader Sanai, Michael Weller, Wolfgang Wick, Riccardo Soffietti, David A. Reardon, Manish K. Aghi, Evanthia Galanis, Patrick Y. Wen, Martin J. van den Bent, Susan M. Chang	42
12	Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment 2020 ·Neuro-Oncology ·Raymond Y. Huang, Robert J. Young, Benjamin M. Ellingson, Harini Veeraraghavan, (unknown), Florent Tixier, Hyemin Um, (unknown), Tracy Luks, John Kim, Elizabeth R. Gerstner, David Schiff, Katherine B. Peters, Ingo K. Mellinghoff, Susan M. Chang, Timothy F. Cloughesy, Patrick Y. Wen	26
13	The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation 2019 ·Cancer Discovery ·Lin Wang, Husam Babikir, Sören Müller, Garima Yagnik, Karin Shamardani, Francisca Catalan, Gary Kohanbash, Beatriz Alvarado, Elizabeth Di Lullo, Arnold R. Kriegstein, Sumedh S. Shah, Harsh Wadhwa, Susan M. Chang, Joanna J. Phillips, Manish K. Aghi, Aarón Díaz	194
14	Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications 2019 ·Neuro-Oncology ·Adrienne Boire, Dieta Brandsma, Priscilla K. Brastianos, Émilie Le Rhun, Manmeet S. Ahluwalia, Larry Junck, Michael Glantz, Morris D. Groves, Eudocia Q. Lee, Nancy U. Lin, Jeffrey Raizer, Roberta Rudà, Michael Weller, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang, Patrick Y. Wen, Riccardo Soffietti	107
15	Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR 2018 ·JCI Insight ·Spencer C. Behr, Javier Villanueva-Meyer, Yan Li, Yung-Hua Wang, Junnian Wei, (unknown), (unknown), (unknown), Kenneth T. Gao, (unknown), Soonmee Cha, David M. Wilson, Youngho Seo, Sarah J. Nelson, Susan M. Chang, Michael J. Evans	21
16	Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group 2018 ·Neuro-Oncology ·Nils D. Arvold, Terri S. Armstrong, Katherine E. Warren, Susan M. Chang, Lisa M. DeAngelis, Jaishri O. Blakeley, Marc C. Chamberlain, Erin Dunbar, Herbert H. Loong, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Ying Yuan, Michael Weller, Martin J. van den Bent, Patrick Y. Wen	37
17	Early Childhood Stimulation Benefits Adult Competence and Reduces Violent Behavior 2011 ·PEDIATRICS ·Susan Walker, Susan M. Chang, Marcos Vera‐Hernández, Sally Grantham‐McGregor	211
18	Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study 2011 ·Journal of Clinical Oncology ·John de Groot, Kathleen R. Lamborn, Susan M. Chang, Mark R. Gilbert, Timothy F. Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank S. Lieberman, H. Ian Robins, Minesh P. Mehta, Andrew B. Lassman, Lisa M. DeAngelis, W.K. Alfred Yung, Alice P. Chen, Michael D. Prados, Patrick Y. Wen	168
19	Electronic Marketing Communications: An Evolving Environment, but Similar Story Regarding the Perception of Unsolicited Commercial E-Mail and Postal Direct Mail 2011 ·Journal of Promotion Management ·Susan M. Chang, Mariko Morimoto	2
20	GENETIC ABERRATIONS IN GLIOMATOSIS CEREBRI 2007 ·Neurosurgery ·Marcus Ware, Yuichi Hirose, Bernd W. Scheithauer, Ru-Fang Yeh, Mary Catherine Mayo, Justin S. Smith, Susan M. Chang, Soonmee Cha, Tarık Tihan, Burt G. Feuerstein	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact